The 38 small molecule compounds were molecularly docked with seven hub genes, and the results showed that most drugs had good binding affinity with AURKA, CDK1 and EZH2 proteins, and had the potential to become inhibitors of the corresponding targets, thereby playing a role in the treatment of SCCE. This evidence concerns the gene AURKA and cervical small cell carcinoma.